Literature DB >> 10461428

The imbalance between coagulation and fibrinolysis is related to the severity of the illness and the prognosis in sepsis.

K J Park1, H J Kim, S C Hwang, S M Lee, Y H Lee, M H Hahn, S K Kim, W Y Lee.   

Abstract

OBJECTIVES: The coagulation and fibrinolytic system appears to be activated by the septic process independently, leading to the syndrome of disseminated intravascular coagulation (DIC). In this study, we investigated the changes within the hemostatic system related to the severity of the illness and the prognosis in patients with sepsis.
METHODS: Plasma thrombin-antithrombin III (TAT) and plasmin-alpha 2-antiplasmin (PAP) complexes were measured using ELISA methods in 32 patients with sepsis and 20 controls and were analyzed according to the APACHE III scores and survival of the patients.
RESULTS: Plasma TAT and PAP in patients with sepsis were significantly higher than controls. Nonsurvivors showed greater levels of TAT (21.7 +/- 22.3 ng/mL) and lower levels of PAP (628.4 +/- 378.1 ng/mL) than survivors (TAT: 11.1 +/- 11.2 ng/mL; PAP: 857.1 +/- 364.1 ng/mL). The imbalance between coagulation and fibrinolysis described as TAT/PAP ratio was closely related with APACHE III scores in patients with sepsis (r = 0.47) and the TAT/PAP ratio in nonsurvivors was significantly higher compared with survivors (34.4 +/- 21.4 vs. 14.4 +/- 13.8).
CONCLUSION: In sepsis, both coagulation and the fibrinolysis system are activated and the imbalance between coagulation and fibrinolysis predisposes to the hypercoagulation state and is closely related to the severity of the disease and the prognosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461428      PMCID: PMC4531923          DOI: 10.3904/kjim.1999.14.2.72

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  18 in total

1.  Alterations in coagulation and fibrinolysis during sepsis.

Authors:  A Kidokoro; T Iba; M Fukunaga; Y Yagi
Journal:  Shock       Date:  1996-03       Impact factor: 3.454

2.  Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay.

Authors:  H Pelzer; A Schwarz; N Heimburger
Journal:  Thromb Haemost       Date:  1988-02-25       Impact factor: 5.249

3.  Plasminogen activator inhibitor 1: a new prognostic marker in septic shock.

Authors:  G Pralong; T Calandra; M P Glauser; J Schellekens; J Verhoef; F Bachmann; E K Kruithof
Journal:  Thromb Haemost       Date:  1989-06-30       Impact factor: 5.249

Review 4.  Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock.

Authors:  M G Vervloet; L G Thijs; C E Hack
Journal:  Semin Thromb Hemost       Date:  1998       Impact factor: 4.180

5.  Hemostatic abnormalities and the severity of illness in patients at the onset of clinically defined sepsis. Possible indication of the degree of endothelial cell activation?

Authors:  B Leithäuser; F R Matthias; U Nicolai; R Voss
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

Review 6.  Coagulation disorders in septic shock.

Authors:  L G Thijs; J P de Boer; M C de Groot; C E Hack
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 7.  Pathogenesis of disseminated intravascular coagulation in sepsis.

Authors:  M Levi; H ten Cate; T van der Poll; S J van Deventer
Journal:  JAMA       Date:  1993-08-25       Impact factor: 56.272

8.  Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.

Authors:  K Kario; T Matsuo; K Kodama; M Matsuo; K Yamamoto; H Kobayashi
Journal:  Haemostasis       Date:  1992

9.  Fibrinolysis and coagulation in patients with infectious disease and sepsis.

Authors:  J Philippé; F Offner; P J Declerck; G Leroux-Roels; D Vogelaers; G Baele; D Collen
Journal:  Thromb Haemost       Date:  1991-03-04       Impact factor: 5.249

Review 10.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

View more
  1 in total

Review 1.  The protein C pathway and pathologic processes.

Authors:  F J Castellino; V A Ploplis
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.